Trade Policy & Tariff Risks:
Donald Trump escalated trade rhetoric, signaling higher tariffs on countries importing Russian energy, and previewing new tariffs on semiconductors and pharmaceuticals within days. This raises geopolitical and supply chain uncertainty—key risks for NSDQ 100 tech and healthcare stocks, particularly chipmakers, drug manufacturers, and firms exposed to global trade.
Swiss Tariff Dispute:
Swiss President Keller-Sutter is in Washington seeking to lower a newly imposed 39% tariff—highlighting the broader unpredictability of US trade actions, which could fuel market volatility and weigh on investor sentiment.
Ukraine Conflict & Sanctions Outlook:
As the US pushes toward an Aug. 8 deadline to resolve the Ukraine conflict, Trump's envoy is in Moscow. Potential Kremlin concessions (e.g., halting airstrikes) may reduce geopolitical risk premiums, especially for defense, energy, and global consumer tech firms.
Federal Reserve & Rate Policy:
With Fed Governor Kugler resigning, Trump is expected to name a replacement this week. His ongoing pressure on the Fed to cut rates adds policy uncertainty. This could support rate-sensitive NSDQ stocks in the near term, especially growth names in tech, if dovish expectations build.
Takeaway for NSDQ100 Traders:
Expect increased volatility around tariff news, Fed appointments, and geopolitical headlines. Traders should watch for:
Semiconductor stocks (e.g., NVDA, AMD, INTC) under pressure from tariff threats.
Big tech and biotech swings tied to pharma trade policy.
Potential relief rallies if Russia concessions materialize or Fed commentary turns dovish.
Key Support and Resistance Levels
Resistance Level 1: 23300
Resistance Level 2: 22430
Resistance Level 3: 23680
Support Level 1: 22677
Support Level 2: 22580
Support Level 3: 22388
This communication is for informational purposes only and should not be viewed as any form of recommendation as to a particular course of action or as investment advice. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Opinions, estimates and assumptions expressed herein are made as of the date of this communication and are subject to change without notice. This communication has been prepared based upon information, including market prices, data and other information, believed to be reliable; however, Trade Nation does not warrant its completeness or accuracy. All market prices and market data contained in or attached to this communication are indicative and subject to change without notice.
Donald Trump escalated trade rhetoric, signaling higher tariffs on countries importing Russian energy, and previewing new tariffs on semiconductors and pharmaceuticals within days. This raises geopolitical and supply chain uncertainty—key risks for NSDQ 100 tech and healthcare stocks, particularly chipmakers, drug manufacturers, and firms exposed to global trade.
Swiss Tariff Dispute:
Swiss President Keller-Sutter is in Washington seeking to lower a newly imposed 39% tariff—highlighting the broader unpredictability of US trade actions, which could fuel market volatility and weigh on investor sentiment.
Ukraine Conflict & Sanctions Outlook:
As the US pushes toward an Aug. 8 deadline to resolve the Ukraine conflict, Trump's envoy is in Moscow. Potential Kremlin concessions (e.g., halting airstrikes) may reduce geopolitical risk premiums, especially for defense, energy, and global consumer tech firms.
Federal Reserve & Rate Policy:
With Fed Governor Kugler resigning, Trump is expected to name a replacement this week. His ongoing pressure on the Fed to cut rates adds policy uncertainty. This could support rate-sensitive NSDQ stocks in the near term, especially growth names in tech, if dovish expectations build.
Takeaway for NSDQ100 Traders:
Expect increased volatility around tariff news, Fed appointments, and geopolitical headlines. Traders should watch for:
Semiconductor stocks (e.g., NVDA, AMD, INTC) under pressure from tariff threats.
Big tech and biotech swings tied to pharma trade policy.
Potential relief rallies if Russia concessions materialize or Fed commentary turns dovish.
Key Support and Resistance Levels
Resistance Level 1: 23300
Resistance Level 2: 22430
Resistance Level 3: 23680
Support Level 1: 22677
Support Level 2: 22580
Support Level 3: 22388
This communication is for informational purposes only and should not be viewed as any form of recommendation as to a particular course of action or as investment advice. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Opinions, estimates and assumptions expressed herein are made as of the date of this communication and are subject to change without notice. This communication has been prepared based upon information, including market prices, data and other information, believed to be reliable; however, Trade Nation does not warrant its completeness or accuracy. All market prices and market data contained in or attached to this communication are indicative and subject to change without notice.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.